Anti-PERT/ TPO/ MSA monoclonal antibody

Anti-PERT/ TPO/ MSA antibody for FACS & in-vivo assay

Target products collectionGo to TPO/TPO products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T51120-Ab-1/ GM-Tg-hg-T51120-Ab-2Anti-Human TPO monoclonal antibodyHuman
GM-Tg-rg-T51120-Ab-1/ GM-Tg-rg-T51120-Ab-2Anti-Rat TPO monoclonal antibodyRat
GM-Tg-mg-T51120-Ab-1/ GM-Tg-mg-T51120-Ab-2Anti-Mouse TPO monoclonal antibodyMouse
GM-Tg-cynog-T51120-Ab-1/ GM-Tg-cynog-T51120-Ab-2Anti-Cynomolgus/ Rhesus macaque TPO monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T51120-Ab-1/ GM-Tg-felg-T51120-Ab-2Anti-Feline TPO monoclonal antibodyFeline
GM-Tg-cang-T51120-Ab-1/ GM-Tg-cang-T51120-Ab-2Anti-Canine TPO monoclonal antibodyCanine
GM-Tg-bovg-T51120-Ab-1/ GM-Tg-bovg-T51120-Ab-2Anti-Bovine TPO monoclonal antibodyBovine
GM-Tg-equg-T51120-Ab-1/ GM-Tg-equg-T51120-Ab-2Anti-Equine TPO monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T51120-Ab-1/ GM-Tg-hg-T51120-Ab-2; GM-Tg-rg-T51120-Ab-1/ GM-Tg-rg-T51120-Ab-2;
GM-Tg-mg-T51120-Ab-1/ GM-Tg-mg-T51120-Ab-2; GM-Tg-cynog-T51120-Ab-1/ GM-Tg-cynog-T51120-Ab-2;
GM-Tg-felg-T51120-Ab-1/ GM-Tg-felg-T51120-Ab-2; GM-Tg-cang-T51120-Ab-1/ GM-Tg-cang-T51120-Ab-2;
GM-Tg-bovg-T51120-Ab-1/ GM-Tg-bovg-T51120-Ab-2; GM-Tg-equg-T51120-Ab-1/ GM-Tg-equg-T51120-Ab-2
Products NameAnti-TPO monoclonal antibody
Formatmab
Target NameTPO
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Diagnostic target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TPO benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PERT/ TPO/ MSA VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-T51120
    Target NameTPO
    Gene ID7173,22018,54314,721610,403521,101098706,525013,100072955
    Gene Symbol and SynonymsMSA,TDH2A,TPO,TPX
    Uniprot AccessionP07202,P14650,Q8HYB7
    Uniprot Entry NamePERT_HUMAN,PERT_RAT,PERT_CANLF
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Diagnostics Biomarker
    DiseaseN/A
    Gene EnsemblENSG00000115705
    Target ClassificationN/A

    The target: TPO, gene name: TPO, also named as MSA, TDH2A, TPX. This gene encodes a membrane-bound glycoprotein. The encoded protein acts as an enzyme and plays a central role in thyroid gland function. The protein functions in the iodination of tyrosine residues in thyroglobulin and phenoxy-ester formation between pairs of iodinated tyrosines to generate the thyroid hormones, thyroxine and triiodothyronine. Mutations in this gene are associated with several disorders of thyroid hormonogenesis, including congenital hypothyroidism, congenital goiter, and thyroid hormone organification defect IIA. Multiple transcript variants encoding distinct isoforms have been identified for this gene, but the full-length nature of some variants has not been determined. [provided by RefSeq, May 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.